Prisons and Drugs- Lisbon Expert meeting
How can we tackle drug challenges in prisons effectively? Top experts gathered to address the high rates of substance use among people living in prison. Key takeaways:
- Tools that track ...
Articles
Improving Primary Care Services for Imprisoned Women with Serious Mental Illness (IP-SIS) Study
The IP-SIS study (Improving Primary Care Services for Imprisoned Women with Severe Mental Illness) is currently exploring the range of primary care services delivered to imprisoned women with severe mental ...
Survey open now for Priorities & Objectives in Orthopaedic Trauma (POINT) research study
Calling musculoskeletal health researchers in Malawi, Tanzania and South africa - survey open now for Priorities & Objectives in Orthopaedic Trauma (POINT) research study Priorities & Objectives in Orthopaedic ...
What Nurses Need: Support That Goes Beyond Funding
Image by Louis Karasinski-Stanley featuring research nurses Amina Suleiman Rajah, Mwanamvua (Mwana) Boga and Rubina Qasim This is the second article in a two-part series on nurses leading change in ...
Transforming Nursing Research: The Pump Priming Research Award and Three Trailblazers
Image by Louis Karasinski-Stanley featuring research nurses Amina Suleiman Rajah, Mwanamvua (Mwana) Boga and Rubina Qasim This is the first article in a two-part series on nurses leading change in ...
News
CEPI launches a Call for Proposal for innovative analytical technologies to improve vaccine manufacturing speed and equitable access
Deadline for application: 1 May 2026. An application may be submitted at any time; the review process will involve quarterly reviews throughout the 12-month application period
CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more
SPEAC's Companion Guide for Single Organ Cutaneous Vasculitis
SPEAC has released a comprehensive Companion Guide for the Brighton Collaboration Case Definition of Single Organ Cutaneous Vasculitis (SOCV)
SPEAC announces the release of a comprehensive Companion Guide for the Brighton Collaboration Case Definition of Single Organ Cutaneous Vasculitis (SOCV). This new resource combines a wealth of tools and guidance to standardize vaccine safety assessments and pharmacovigilance efforts worldwide. Read more
Phase IV post-approval studies in the context of vaccines approved through accelerated procedures: Case study, CHIKUNGUNYA vaccines
Workshop held in São Paulo, Brazil on 19 & 20 March 2025
CEPI and ANVISA hosted this workshop to update global regulators on the marketing authorisation and clinical development plans in preparation for phase IV studies and future global approvals. There was robust dialogue and participation from 18 countries representing 14 NRAs. Read more
Rift Valley Fever workshop summary
published in Vaccine, Volume 54, 30 April 2025
In June 2024, CEPI convened a workshop in Nairobi, Kenya, to discuss epidemiology and modeling for human RVF vaccine development, bringing together representatives from RVF-endemic countries, global collaborators, and international health organizations. This paper summarizes the workshop discussions and priorities. Read more
African Vaccine Manufacturing Supply Chain Forum 2024 – actions delivery update
Africa CDC and CEPI update on mitigations to address assessed African input material supply chain challenges
The African Union has set an ambitious goal: by 2040 over 60% of the vaccines needed for Africa’s population should be produced locally. A sustainable supply chain for the specialized input materials that go into making vaccines will be required Read more
CEPI has launched the Research Preparedness Program (RPP)
The RPP will support both advanced-stage clinical development of CEPI’s portfolio vaccines against priority diseases and the 100 Days Mission
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
| Older News Here |
Resources
Pandemic Preparedness & Response Playbook
In collaboration with TGHN, CEPI created this playbook to bring together the many tools, resources and materials generated for pandemic preparedness and response from the COVID-19 pandemic. The first (Regulatory) chapter is now available.
TRANSVAC Academy Training Courses
TRANSVAC Academy offers training modules in vaccine R&D including grant management, statistics, cytometry and advanced process development. CEPI funded scholarships are provided to selected applicants from LMICs.
SPEAC: THE SAFETY PLATFORM FOR EMERGENCY VACCINES
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
